This brand name is authorized in Nigeria.
The drug ZISTY contains one active pharmaceutical ingredient (API):
1
|
UNII
E7199S1YWR - LISINOPRIL
|
|
Lisinopril is a peptidyl dipeptidase inhibitor. It inhibits the angiotensin-converting enzyme (ACE) that catalyses the conversion of angiotensin I to the vasoconstrictor peptide, angiotensin II. Angiotensin II also stimulates aldosterone secretion by the adrenal cortex. Inhibition of ACE results in decreased concentrations of angiotensin II which results in decreased vasopressor activity and reduced aldosterone secretion. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-5866 | Caplet | Zisty 10 Caplet TAB 10 mg 2X14 | 52 RNW-PP-292848 Zisty 10 Caplet Lisnopril Caplet BP 10mg Lisinopril Dihydrate 10mg A4-5866 Drugs Imported Products 214 Prescription Only Medicine (POM) 11/10/2022 AQUATIX PHARMACEUTICALS LIMITED, 7, Sapara Williams Street, Industrial Estate, Ikeja. Lagos. Nigeria. 7064946450 aquatixnigeria@gmail.com MCW HEALTHCARE ( P) LTD,, 286, 287- A, 287-B, SECTOR- INDUSTRIAL AREA, SANWER ROAD, INDORE( M.P.)., India | 25/05/2023 |
| A4-5867 | Caplet | Zisty 5 Caplet TAB 5 mg 2X14 | 51 RNW-PP-292842 Zisty 5 Caplet Lisinopril Caplet BP 5mg Lisinopril Dihydrate BP 5mg A4-5867 Drugs Imported Products 214 Prescription Only Medicine (POM) 11/10/2022 AQUATIX PHARMACEUTICALS LIMITED, 7, Sapara Williams Street, Industrial Estate, Ikeja. Lagos. Nigeria. 7064946450 aquatixnigeria@gmail.com MCW HEALTHCARE ( P) LTD,, 286, 287- A, 287-B, SECTOR- INDUSTRIAL AREA, SANWER ROAD, INDORE( M.P.)., India | 25/05/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| C09AA03 | Lisinopril | C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-5866, A4-5867 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.